Botulinum toxin for myofascial pain syndromes in adults

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Soares, Adriana ^a   Andriolo, Régis B ^a   Atallah, Álvaro N ^a   Da Silva, Edina M K ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

CLINICAL TRIAL; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FLU LIKE SYNDROME; HUMAN; MUSCLE WEAKNESS; MYOFASCIAL PAIN; OUTCOME ASSESSMENT; RASH; REVIEW; VISUAL ANALOG SCALE; XEROSTOMIA;

EID: 70249118125     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007533     Document Type: Review

References (45)

1. Argoff CE. A focused review on the use of botulinum toxins for neuropathic pain. Clinical Journal of Pain 2002;18(6 Suppl):S177-81. [PUBMED: 12569966]
2. Baldry P. Management of myofascial trigger point pain. Acupuncture in Medicine: Journal of the British Medical Acupuncture Society 2002;20(1):2-10. [PUBMED: 11926600] (Pubitemid 34258752)
3. Borodic GE, Acquadro M, Johnson EA. Botulinum toxin therapy for pain and inflammatory disorders: Mechanisms and therapeutic effects. Expert Opinion on Investigational Drugs 2001;10:1531-1544 (Pubitemid 32717333)
4. Brashear A, Lew MF, Dykstra DD, Comella CL, Factor SA, Rodnitzky RL. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 1999;53:1439-1446 (Pubitemid 29491934)
5. Bron C, Wensing M, Franssen JL, Oostendorp RA. Treatment of myofascial trigger points in common shoulder disorders by physical therapy: a randomized controlled trial [ISRCTN75722066]. BMC Musculoskeletal Disorders 2007;5(8):107. [PUBMED: 17983467] (Pubitemid 351278382)
6. Dundar U, Evcik D, Samli F, Pusak H, Kavuncu V. The effect of gallium arsenide aluminium laser therapy in the management of cervical myofascial pain syndrome: a double blind, placebo-controlled study. Clinical Rheumatology 2007;26(6):930-934 [PUBMED: 17021664] (Pubitemid 46951292)
7. Edwards J. The importance of postural habits in perpetuating myofascial trigger point pain. Acupuncture in Medicine: Journal of the British Medical Acupuncture Society 2005;23(2):77-82. [PUBMED: 16025788] (Pubitemid 40978886)
8. Ernberg M. The physiopathological mechanisms behind chronic myofacial pain. Lakartidningen 2002;99(32-33):3206-3210 [PUBMED: 12219474]
9. Esenyel M, Caglar N, Aldemir T. Treatment of Myofascial Pain. Lippincott Williams & Wilkins 2000;79(1):48-52.
10. Fishbain DA, Goldberg M, Meagher BR, et al.Male and female chronic pain patient's categories by DSM-III psychiatric diagnostic criteria. Pain 1986;26:181-197 (Pubitemid 16046063)
11. Flor H, Birbaumer N. Comparison of the efficacy of electromyographic biofeedback, cognitive-behavioral therapy, and conservative medical interventions in the treatment of chronic musculoskeletal pain. Journal of Consulting and Clinical Psychology 1993;61(4):653-658 (Pubitemid 23230088)
12. Fricton JR, Kroening R, Haley D, Siegert R. Myofascial pain syndrome of the head and neck: A review of clinical characteristics of 164 patients. Oral Surgery 1985;60:615-623 (Pubitemid 16172639)
13. Fricton J. Myofascial Pain. Baillière's ClinicaI Rheumatology 1994;8(4):857-880
14. Gerwin RD. A study of 96 subjects examined both for fibromyalgia and myofascial pain [Abstract]. Journal of Muskuloskeletal Pain 1995;3 (Supp 1):121.
15. Guststein M. Diagnosis and treatment of muscular rheumatism. The British Journal of Physical Medicine 1938;1:302-321
16. Han SC, Harrison P. Myofascial pain syndrome and trigger-point management. Regional Anesthesia 1997;22(1):89-101. [PUBMED: 9010953] (Pubitemid 27058281)
17. Hanten WP, Olson SL, Butts NL, Nowicki AL. Effectiveness of a home program of ischemic pressure followed by sustained stretch for treatment of myofascial trigger points. Physical Therapy 2000;80(10):997-1003. [PUBMED: 11002435]
18. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ (Clinical Research Ed.) 2003;327:555-557
19. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
20. Hong CZ. Lidocaine injection versus dry needling to myofascial trigger point - The importance of the local twitch response. American Journal of Physical Medicine and Rehabilitation 1994;73(4):256-263
21. Smith HS, Audette J, Royal MA. Botulinum toxin in pain management of soft tissue syndromes. Clinical Journal of Pain 2002;18(6):S147-54. (Pubitemid 35285598)
22. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. The Journal of the American Medical Association 1999;282:1054-1060 (Pubitemid 29436453)
23. Kam E, Eslick G, Campbell I. An audit of the effectiveness of acupuncture on musculoskeletal pain in primary health care. Acupuncture in Medicine: Journal of the British Medical Acupuncture Society 2002;20(1):35-38 [PUBMED: 11926604] (Pubitemid 34258758)
24. Kern U, Martin C, Scheicher S, Müller H. Does botulinum toxin A make prosthesis use easier for amputees?. Journal of Rehabilitation Medicine 2004;36(5):238-239 [PUBMED: 15626165] (Pubitemid 39317471)
25. Laskin DM. Etiology of the pain-dysfunction syndrome. Journal of the American Dental Association 1969;79:147-153
26. Lew MF. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction. The Clinical Journal of Pain 2002;18(6 suppl):S142-6. [PUBMED: 12569961]
27. McMillan AS, Nolan A, Kelly PJ. The efficacy of dry needling and procaine in the treatment of myofascial pain in the jaw muscles. Journal of Orofacial Pain 1997;11:307-314 (Pubitemid 127711496)
28. Pereda CA, Jaeger JU, Carmona L. Systematic review: can botulinum toxin be recommended as treatment for pain in myofascial syndrome? [Revisión sistemática: es recomendable el empleo de toxina botulínica como tratamiento del dolor en el síndrome miofascial?]. Systematic Review 2006;2(4):173-182
29. Pettengill CA, Reisner-Keller L. The use of tricyclic antidepressants for the control of chronic orofacial pain. Cranio 1997;15(1):53-56 [PUBMED: 9586488] (Pubitemid 127535530)
30. Roth RS, Horowitz K, Bachman JE. Chronic myofascial pain: knowledge of diagnosis and satisfaction with treatment. Archives of Physical Medicine and Rehabilitation 1998;79(8):966-970 [PUBMED: 9710171] (Pubitemid 28368988)
31. Royal MA, Gunyea I, Bhakta B, et al.Botulinum toxin type A in the treatment of refractory myofascial pain. Neurology 2001;56(Suppl 3):A350. Abstract.
32. Schiffman EL, Fricton JR, Haley DP, Shapiro BL. The prevalence and treatment needs of subjects with temporomandibular disorders. Journal of the American Dental Association 1990;120:295-303.
33. Sellin LC, Thesleff S. Pre- and post-synaptic actions of botulinum toxin at the rat neuromuscular junction. Journal of Physiology 1981;317:487-495 [PUBMED: 6273549] (Pubitemid 12205888)
34. Simons DG Ref SOLA 1A 3. Muscle pain syndromes. Part II. American Journal of Physical Medicine 1976;55:15-42.
35. Simons DG, Travell JG, Simons LS. Travell and Simons' Myofascial Pain and Dysfunction: The Trigger Point Manual. 2. Vol. 1: Upper Half of the Body, Baltimore: Lippincott, Williams & Wilkins, 1999.
36. Singer E, Dionne R. A controlled evaluation of ibuprofen and diazepam for chronic orofacial muscle pain. Journal of Orofacial Pain 1997;11(2):139-146 [PUBMED: 10332320] (Pubitemid 127711780)
37. Skootsky SA, Jaeger B, Oye RK. Prevalence of myofascial pain in general internal medicine practice. The Western Journal of Medicine 1989;151(2):157-160 (Pubitemid 19206207)
38. Sola AE, Rodenberg ML, Gettys BB. Incidence of hypersensitive areas in posterior shoulder muscles. American Journal of Physical Medicine 1955;34:585-590
39. Solberg WK. Temporomandibular disorders: masticatory myalgia and its management. British Dental Journal 1986;160:351-356
40. Srbely JZ, Dickey JP. Randomized controlled study of the antinociceptive effect of ultrasound on trigger point sensitivity: novel applications in myofascial therapy?. Clinical Rehabilitation 2007;21(5):411-417 [PUBMED: 17613561]
41. Borg-Stein J. Treatment of fibromyalgia, myofascial pain, and related disorders. Physical Medicine and Rehabilitation Clinics of North America 2006;17(2):491-510. [PUBMED: 16616279]
42. Talaat AM, el-Dibany MM, el-Garf A. Physical therapy in the management of myofacial pain dysfunction syndrome. Annals of Otology, Rhinology and Laryngology 1986;95(3 pt 1):225-228 [PUBMED: 3717846]
43. Tang JL, Liu JLY. Misleading funnel plot for detection of bias in meta-analysis. Journal of Clinical Epidemiology 2000;53:477-484
44. Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. Journal of Clinical Epidemiology 2000;53:207-216 (Pubitemid 30151226)
45. Unnebrink K, Windeler J. Intention-to-treat methods for dealing with missing values in clinical trials of progressively deteriorating diseases. Statistics in Medicine 2001;20:3931-3946